Search research articles
Contact Us
Filters
Showing results (161-170 of 291) with videos related to
Page
of 30
Sort By:
Microbiology Spectrum
|
November 25, 2025
Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines
Marta Boza, Adam Abdeljawad, Stefan Slamanig, et al.
Scientific Reports
|
November 13, 2021
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Influenza and Other Respiratory Viruses
|
May 21, 2009
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells
Isabelle Legastelois, Adolfo Garcia-Sastre, Peter Palese, et al.
Journal of Virology
|
December 17, 2008
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza
John Steel, Anice C Lowen, Lindomar Pena, et al.
Biorxiv : the Preprint Server for Biology
|
May 5, 2021
Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Mbio
|
March 23, 2017
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
Madhusudan Rajendran, Raffael Nachbagauer, Megan E Ermler, et al.
Nature Communications
|
February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
Dmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Journal of Virology
|
September 2, 2011
The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model
Yi-ying Chou, Randy A Albrecht, Natalie Pica, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2022
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
Xueyong Zhu, Julianna Han, Weina Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2016
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
Paul E Leon, Wenqian He, Caitlin E Mullarkey, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 291) with videos related to
Sort By:
Page
of 30
Microbiology Spectrum
|
November 25, 2025
Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines
Marta Boza, Adam Abdeljawad, Stefan Slamanig, et al.
Scientific Reports
|
November 13, 2021
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Influenza and Other Respiratory Viruses
|
May 21, 2009
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells
Isabelle Legastelois, Adolfo Garcia-Sastre, Peter Palese, et al.
Journal of Virology
|
December 17, 2008
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza
John Steel, Anice C Lowen, Lindomar Pena, et al.
Biorxiv : the Preprint Server for Biology
|
May 5, 2021
Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Mbio
|
March 23, 2017
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
Madhusudan Rajendran, Raffael Nachbagauer, Megan E Ermler, et al.
Nature Communications
|
February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
Dmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Journal of Virology
|
September 2, 2011
The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model
Yi-ying Chou, Randy A Albrecht, Natalie Pica, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2022
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
Xueyong Zhu, Julianna Han, Weina Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2016
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
Paul E Leon, Wenqian He, Caitlin E Mullarkey, et al.
Page
of 30